2-aminopurine has been researched along with Cancer of Pancreas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Pan, Y; Qin, Y; Xiang, R; Yang, J; Yang, SY; Zheng, M; Zhong, L; Zhou, S | 1 |
| Granberg, D; Hassan, S; Larsson, DE; Larsson, R; Oberg, K | 1 |
2 other study(ies) available for 2-aminopurine and Cancer of Pancreas
| Article | Year |
|---|---|
A preclinical evaluation of SKLB261, a multikinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancer.
Topics: 2-Aminopurine; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Evaluation, Preclinical; ErbB Receptors; Female; G1 Phase; Humans; Mice, Nude; Neoplasm Metastasis; Pancreatic Neoplasms; Piperazines; Protein Kinase Inhibitors; Rats, Sprague-Dawley; Recombinant Proteins; Resting Phase, Cell Cycle; Signal Transduction; src-Family Kinases; Vascular Endothelial Growth Factor Receptor-2; Zebrafish | 2015 |
Combination analyses of anti-cancer drugs on human neuroendocrine tumor cell lines.
Topics: 2-Aminopurine; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoid Tumor; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Emetine; Humans; Naphthoquinones; Neuroendocrine Tumors; Pancreatic Neoplasms | 2009 |